Literature DB >> 27662576

Radiation Dose Comparison Between 70 kVp and 100 kVp With Spectral Beam Shaping for Non-Contrast-Enhanced Pediatric Chest Computed Tomography: A Prospective Randomized Controlled Study.

Meike Weis1, Thomas Henzler, John W Nance, Holger Haubenreisser, Mathias Meyer, Sonja Sudarski, Stefan O Schoenberg, K Wolfgang Neff, Claudia Hagelstein.   

Abstract

OBJECTIVE: The aim of this prospective randomized controlled study was to compare 2 techniques for radiation dose reduction in non-contrast-enhanced pediatric chest computed tomography (CT): low peak kilovoltage imaging at 70 kVp and spectral beam shaping at 100 kVp using a dedicated tin filter (100-kVp Sn).
MATERIALS AND METHODS: All chest CT examinations were performed on a third-generation dual-source CT system (SOMATOM Force; Siemens Healthineers, Germany). Fifty children (mean age, 6.8 ± 5.1 years) were examined using the 100-kVp Sn protocol, whereas 25 children received the 70-kVp protocol (mean age, 5.7 ± 5.2 years; 2:1 randomization scheme). Radiation metrics and organ doses were compared between acquisition techniques using commercially available radiation dose analysis software (Radimetrics Inc, Bayer AG, Toronto, Ontario, Canada). Objective image quality, expressed by signal-to-noise ratio and subjective image quality based on a 4-point scale (1, best; 4, worst image quality), were compared.
RESULTS: Volume CT dose index and size-specific dose estimate were significantly lower in the 100-kVp Sn group compared with the 70-kVp group (0.19 ± 0.12 mGy vs 0.81 ± 0.70 mGy and 0.34 ± 0.13 mGy vs 1.48 ± 1.11 mGy; P < 0.0001 for both). Accordingly, mean effective dose was significantly lower for the 100-kVp Sn examinations (0.21 ± 0.10 mSv) compared with the 70-kVp examinations (0.83 ± 0.49 mSv; P < 0.0001). Calculated organ doses were also significantly lower using the 100-kVp Sn protocol when compared with the 70-kVp protocol; for example, breast dose was reduced by a factor of 4.3. Signal-to-noise ratio was slightly superior for 70-kVp images while lung image quality of the 100-kVp Sn protocol was preferred in subjective analysis (P = 0.0004).
CONCLUSIONS: Pediatric chest CT performed at 100 kVp with an additional tin filter for spectral shaping significantly reduces radiation dose when compared with low peak kilovoltage imaging at 70 kVp and therefore should be preferred in non-contrast-enhanced pediatric chest CT examinations, particularly (given the improved subjective image quality) when the main focus is evaluation of the lung parenchyma.

Entities:  

Mesh:

Year:  2017        PMID: 27662576     DOI: 10.1097/RLI.0000000000000325

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  17 in total

1.  Pediatric chest computed tomography at 100 kVp with tin filtration: comparison of image quality with 70-kVp imaging at comparable radiation dose.

Authors:  Sophie Vivier; Valérie Deken; Younes Arous; Jean-Baptiste Faivre; Alain Duhamel; Antoine Deschildre; Thomas Flohr; Jacques Remy; Martine Remy-Jardin
Journal:  Pediatr Radiol       Date:  2019-12-18

2.  A prospective evaluation of contrast and radiation dose and image quality in cardiac CT in children with complex congenital heart disease using low-concentration iodinated contrast agent and low tube voltage and current.

Authors:  Qiao-Ru Hou; Wei Gao; Ai-Min Sun; Qian Wang; Hai-Sheng Qiu; Fang Wang; Li-Wei Hu; Jian-Ying Li; Yu-Min Zhong
Journal:  Br J Radiol       Date:  2016-12-07       Impact factor: 3.039

3.  Dose reduction in abdominal CT: The road to submillisievert imaging.

Authors:  Alexander A Fingerle; Peter B Noël
Journal:  Eur Radiol       Date:  2018-04-10       Impact factor: 5.315

4.  Comparison of low- and ultralow-dose computed tomography protocols for quantitative lung and airway assessment.

Authors:  Emily Hammond; Chelsea Sloan; John D Newell; Jered P Sieren; Melissa Saylor; Craig Vidal; Shayna Hogue; Frank De Stefano; Alexa Sieren; Eric A Hoffman; Jessica C Sieren
Journal:  Med Phys       Date:  2017-08-02       Impact factor: 4.071

5.  Chest CT screening in patients with overweight or obesity using spectral shaping at 150 kVp: compared with 120 kVp protocol and spectral shaping at 100 kVp protocol.

Authors:  Jianwen Li; Zhifeng Mai; Zhihong Zhang; Jiamang Cui; Mingjie Yang; Xia Ma; Yan Wang
Journal:  Jpn J Radiol       Date:  2020-02-11       Impact factor: 2.374

6.  Feasibility study of ultra-low-dose dedicated maxillofacial computed tomography using filter-based spectral shaping in patients with craniofacial trauma: assessment of image quality and radiation dose.

Authors:  Ji Young Ha; Hye Jin Baek; Kyeong Hwa Ryu; Eun Cho
Journal:  Quant Imaging Med Surg       Date:  2021-04

7.  Time to Exhale: Additional Value of Expiratory Chest CT in Chronic Obstructive Pulmonary Disease.

Authors:  Joshua Gawlitza; Frederik Trinkmann; Hans Scheffel; Andreas Fischer; John W Nance; Claudia Henzler; Nils Vogler; Joachim Saur; Ibrahim Akin; Martin Borggrefe; Stefan O Schoenberg; Thomas Henzler
Journal:  Can Respir J       Date:  2018-03-04       Impact factor: 2.409

Review 8.  Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis.

Authors:  Jürgen Schäfer; Matthias Griese; Ravishankar Chandrasekaran; Sanjay H Chotirmall; Dominik Hartl
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

9.  Dual-source computed tomography of the lung with spectral shaping and advanced iterative reconstruction: potential for maximum radiation dose reduction.

Authors:  Matthias Wetzl; Matthias S May; Daniel Weinmann; Matthias Hammon; Christoph Treutlein; Martin Zeilinger; Alexander Kiefer; Regina Trollmann; Joachim Woelfle; Michael Uder; Oliver Rompel
Journal:  Pediatr Radiol       Date:  2020-06-17

10.  Radiation dose of chaperones during common pediatric computed tomography examinations.

Authors:  Daniel Overhoff; Meike Weis; Philipp Riffel; Sonja Sudarski; Matthias F Froelich; Peter Fries; Stefan Schönberg; Joshua Gawlitza
Journal:  Pediatr Radiol       Date:  2020-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.